Skip to main content
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 2001;9(4):233–237. doi: 10.1155/S1064744901000382

A Randomized Controlled Trial of Interleukin-1 Receptor Antagonist in a Rabbit Model of Ascending Infection in Pregnancy

Robert S McDuffie Jr 1,, Jill K Davies 2, Kimberly K Leslie 2, Scott Lee 2, Michael P Sherman 3, Ronald S Gibbs 2
PMCID: PMC1784656  PMID: 11916181

Abstract

Objective: To determinewhether treatment with interleukin-1 receptor antagonist (IL1-ra) would affect amniotic fluid concentrations of tumor necrosis factor alpha (TNF-α) and prostaglandins or clinical or microbiological outcomes in a model of ascending bacterial infection in pregnancy.

Methods: Timed pregnant New Zealand white rabbits at 70% of gestation underwent endoscopic inoculation of the cervices with 106–106 cfu Escherichia coli . Animals were randomly assigned in a blinded manner to a 5-h intravenous infusion of human IL1-ra (10 mg/kg) or placebo beginning 1 – 2 h after inoculation. Blood was drawn fromthe does for assay of serum IL1-ra concentration before inoculation, at mid-infusion, after the infusion ended and at necropsy. At necropsy, temperature and cultures were taken, and aspirated amniotic fluid was pooled for assays of TNF-α, prostaglandin E2 (PGE2) and IL1-ra.

Results: Serum IL1-ra concentrations rose to a mean of 2 mg/ml at mid-infusion and fell markedly after the infusion to concentrations barely detectable at necropsy. Between the two groups, there were no significant differences in the rates of fever or positive cultures or in amniotic fluid concentrations of PGE2 or TNF-α.One unique finding was the demonstration that administration of human IL1-ra to the does resulted inmeasurable concentrationsof human IL1-ra in the amniotic fluid.

Conclusions: Treatment with an intravenous infusion of human IL1-ra after cervical inoculation with E. coli did not affect clinical or microbiological outcomes or amniotic fluid concentrations of TNF-α or PGE2. This experiment provides the first demonstration of passageof human IL1-ra from the maternal bloodstreamto the amniotic fluid.

Full Text

The Full Text of this article is available as a PDF (140.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aiura K., Gelfand J. A., Burke J. F., Thompson R. C., Dinarello C. A. Interleukin-1 (IL-1) receptor antagonist prevents Staphylococcus epidermidis-induced hypotension and reduces circulating levels of tumor necrosis factor and IL-1 beta in rabbits. Infect Immun. 1993 Aug;61(8):3342–3350. doi: 10.1128/iai.61.8.3342-3350.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bejar R., Wozniak P., Allard M., Benirschke K., Vaucher Y., Coen R., Berry C., Schragg P., Villegas I., Resnik R. Antenatal origin of neurologic damage in newborn infants. I. Preterm infants. Am J Obstet Gynecol. 1988 Aug;159(2):357–363. doi: 10.1016/s0002-9378(88)80084-x. [DOI] [PubMed] [Google Scholar]
  3. Gibbs R. S., Romero R., Hillier S. L., Eschenbach D. A., Sweet R. L. A review of premature birth and subclinical infection. Am J Obstet Gynecol. 1992 May;166(5):1515–1528. doi: 10.1016/0002-9378(92)91628-n. [DOI] [PubMed] [Google Scholar]
  4. Leslie K. K., Lee S. L., Woodcock S. M., Davies J. K., McDuffie R. S., Jr, Hirsch E., Sherman M. P., Eskens J. L., Gibbs R. S. Acute intrauterine infection results in an imbalance between pro- and anti-inflammatory cytokines in the pregnant rabbit. Am J Reprod Immunol. 2000 May;43(5):305–311. doi: 10.1111/j.8755-8920.2000.430510.x. [DOI] [PubMed] [Google Scholar]
  5. Leviton A. Preterm birth and cerebral palsy: is tumor necrosis factor the missing link? Dev Med Child Neurol. 1993 Jun;35(6):553–558. doi: 10.1111/j.1469-8749.1993.tb11688.x. [DOI] [PubMed] [Google Scholar]
  6. McDuffie R. S., Jr, Sherman M. P., Gibbs R. S. Amniotic fluid tumor necrosis factor-alpha and interleukin-1 in a rabbit model of bacterially induced preterm pregnancy loss. Am J Obstet Gynecol. 1992 Dec;167(6):1583–1588. doi: 10.1016/0002-9378(92)91745-v. [DOI] [PubMed] [Google Scholar]
  7. Vallette J. D., Jr, Goldberg R. N., Suguihara C., Del Moral T., Martinez O., Lin J., Thompson R. C., Bancalari E. Effect of an interleukin-1 receptor antagonist on the hemodynamic manifestations of group B streptococcal sepsis. Pediatr Res. 1995 Nov;38(5):704–708. doi: 10.1203/00006450-199511000-00012. [DOI] [PubMed] [Google Scholar]
  8. Wakabayashi G., Gelfand J. A., Burke J. F., Thompson R. C., Dinarello C. A. A specific receptor antagonist for interleukin 1 prevents Escherichia coli-induced shock in rabbits. FASEB J. 1991 Mar 1;5(3):338–343. doi: 10.1096/fasebj.5.3.1825816. [DOI] [PubMed] [Google Scholar]
  9. Yoon B. H., Romero R., Yang S. H., Jun J. K., Kim I. O., Choi J. H., Syn H. C. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol. 1996 May;174(5):1433–1440. doi: 10.1016/s0002-9378(96)70585-9. [DOI] [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES